Shenzhen Chipscreen Biosciences Co (688321) — Cash Flow-to-Debt Ratio
Shenzhen Chipscreen Biosciences Co (688321) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥2.25 Million could theoretically repay 0% of its total liabilities (CN¥1.98 Billion) in one year. See Shenzhen Chipscreen Biosciences Co free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shenzhen Chipscreen Biosciences Co Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Shenzhen Chipscreen Biosciences Co across 9 annual periods. Also explore net asset growth rate of Shenzhen Chipscreen Biosciences Co to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shenzhen Chipscreen Biosciences Co (2016–2024)
Year-by-year debt coverage analysis for Shenzhen Chipscreen Biosciences Co. For market capitalisation and broader financial context, see Shenzhen Chipscreen Biosciences Co (688321) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | CN¥76.13 Million | CN¥1.67 Billion | ▲ +147.5% |
| 2023 | -0.10x | CN¥-143.21 Million | CN¥1.49 Billion | ▼ -392.4% |
| 2022 | 0.03x | CN¥43.30 Million | CN¥1.32 Billion | ▼ -87.5% |
| 2021 | 0.26x | CN¥124.78 Million | CN¥476.79 Million | ▼ -35.0% |
| 2020 | 0.40x | CN¥93.62 Million | CN¥232.44 Million | ▲ +502.1% |
| 2019 | -0.10x | CN¥-24.55 Million | CN¥245.10 Million | ▼ -205.3% |
| 2018 | 0.10x | CN¥22.78 Million | CN¥239.44 Million | ▲ +616.0% |
| 2017 | 0.01x | CN¥2.73 Million | CN¥205.47 Million | ▼ -95.8% |
| 2016 | 0.32x | CN¥59.77 Million | CN¥189.73 Million | — |